Arkolith/Insider Trading/KDNY/Form 4

Dobmeier Eric

President, CEO, DirectorCHINOOK THERAPEUTICS, INC. (KDNY) · full profile →Form 4 · filed Aug 11, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
12
1 non-derivative · 11 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 11, 2023Disposed to issuer(D)301K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 11, 2023Disposed to issuer(D)64K——0
Aug 11, 2023Disposed to issuer(D)50K——0
Aug 11, 2023Disposed to issuer(D)20K——0
Aug 11, 2023Disposed to issuer(D)31K——0
Aug 11, 2023Disposed to issuer(D)255K$14.73$3.8M0
Aug 11, 2023Disposed to issuer(D)11K——0
Aug 11, 2023Disposed to issuer(D)179K$24.86$4.4M0
Aug 11, 2023Disposed to issuer(D)272K$25.23$6.9M0
Aug 11, 2023Disposed to issuer(D)314K$39.58$12.4M0
Aug 11, 2023Disposed to issuer(D)353K$39.65$14.0M0
Aug 11, 2023Disposed to issuer(D)300K$27.10$8.1M0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-045417) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML